References

References

Eisai Ltd (2013) Zonegran summary of product characteristics [online; accessed 18 December 2013]

European Medicines Agency (2013) European public assessment report: Zonegran [online; accessed 18 December 2013]

European Medicines Agency (2010) Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders [online; accessed 18 December 2013]

European Medicines Agency (2010) Guideline on missing data in confirmatory clinical trials [online; accessed 5 February 2014]

Guerrini R, Rosati A, Segieth J et al. (2013) A randomized phase III trial of adjunctive zonisamide in pedatric patients with partial epilepsy. Epilepsia 54: 1473–80

Guerrini R, Rosati A, Bradshaw K et al. (2014) Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: Results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial. Epilepsia DOI: 10.1111/epi.12548

National Institute for Health and Clinical Excellence (2013) The epilepsies in children and young people. NICE quality standard 27

National Institute for Health and Clinical Excellence (2012) The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE clinical guideline 137

National Institute for Health and Clinical Excellence (2011) Retigabine for the adjunctive treatment of partial onset seizures in epilepsy with and without secondary generalisation. NICE technology appraisal guidance 232

National Institute for Health and Clinical Excellence (2010) Retigabine for the adjunctive treatment of partial onset seizures in epilepsy. NICE technology appraisal final scope

US National Institutes of Health (2013) ClinicalTrials.gov Identifier: NCT01136954 [online; accessed 18 December 2013]